Your browser doesn't support javascript.
loading
Dermatologic manifestations and diagnostic assessments of the Ehlers-Danlos syndromes: A clinical review.
Doolan, Brent J; Lavallee, Mark; Hausser, Ingrid; Pope, F Michael; Seneviratne, Suranjith L; Winship, Ingrid M; Burrows, Nigel P.
Afiliación
  • Doolan BJ; St John's Institute of Dermatology, School of Basic and Medical Biosciences, King's College London, London, UK; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UK. Electronic address: b.doolan@nhs.net.
  • Lavallee M; Department of Orthopedics, University of Pittsburgh Medical Center of Central PA, Pittsburgh, Pennsylvania.
  • Hausser I; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Pope FM; Department of Dermatology, Chelsea and Westminster Hospital NHS Foundation Trust (West Middlesex University Hospital), London, UK.
  • Seneviratne SL; Institute of Immunity and Transplantation, Royal Free Hospital and University College London, London, UK; Nawaloka Hospital Research and Education Foundation, Nawaloka Hospitals, Colombo, Sri Lanka.
  • Winship IM; Department of Genetic Medicine, The Royal Melbourne Hospital, Melbourne, Victoria, Australia; Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.
  • Burrows NP; Department of Dermatology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
J Am Acad Dermatol ; 89(3): 551-559, 2023 09.
Article en En | MEDLINE | ID: mdl-36764582
ABSTRACT

BACKGROUND:

The Ehlers-Danlos syndromes (EDSs) comprise a group of connective tissue disorders that manifest with skin hyperextensibility, easy bruising, joint hypermobility and fragility of skin, soft tissues, and some organs. A correct assessment of cutaneous features along with the use of adjunct technologies can improve diagnostic accuracy.

OBJECTIVES:

To systematically review the cutaneous features and adjunct investigations of EDS.

METHODS:

A search of PubMed and Web of Science for EDS-related cutaneous features and additional investigations was undertaken from publication of the 2017 International Classification of EDS until January 15, 2022.

RESULTS:

One-hundred-and-forty studies involved 839 patients with EDS. The EDS female-to-male ratio was 1.361 (P < .001). A high prevalence of skin hyperextensibility, bruising, and soft skin were noted. Most patients with vascular Ehlers-Danlos syndrome showed venous visibility, skin fragility, and acrogeria. Classical EDS showed subcutaneous spheroids and molluscoid pseudotumours. In patients that underwent skin biopsies, only 30.3% and 71.4% showed features suggestive of EDS using light microscopy and transmission electron microscopy, respectively.

LIMITATIONS:

Retrospective study and small cases numbers for some EDS-subtypes.

CONCLUSIONS:

An accurate clinical diagnosis increases the chances of a molecular diagnosis, particularly for rarer EDS subtypes, whilst decreasing the need for genetic testing where there is a low clinical suspicion for a monogenic EDS-subtype.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades del Tejido Conjuntivo / Síndrome de Ehlers-Danlos Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: J Am Acad Dermatol Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades del Tejido Conjuntivo / Síndrome de Ehlers-Danlos Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: J Am Acad Dermatol Año: 2023 Tipo del documento: Article